These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30509446)

  • 21. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis.
    Machado PM; Baraliakos X; van der Heijde D; Braun J; Landewé R
    Ann Rheum Dis; 2016 Aug; 75(8):1486-93. PubMed ID: 26462728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.
    Poddubnyy D; Sieper J
    Curr Opin Rheumatol; 2014 Jul; 26(4):377-83. PubMed ID: 24807404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
    Appel H; Janssen L; Listing J; Heydrich R; Rudwaleit M; Sieper J
    Arthritis Res Ther; 2008; 10(5):R125. PubMed ID: 18945353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
    Tseng HW; Glant TT; Brown MA; Kenna TJ; Thomas GP; Pettit AR
    BMC Musculoskelet Disord; 2017 May; 18(1):228. PubMed ID: 28558827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J
    Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone formation versus bone resorption in ankylosing spondylitis.
    Schett G
    Adv Exp Med Biol; 2009; 649():114-21. PubMed ID: 19731624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging Scoring Methods in Axial Spondyloarthritis.
    Baraliakos X; Braun J
    Rheum Dis Clin North Am; 2016 Nov; 42(4):663-678. PubMed ID: 27742020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis.
    de Andrade KR; de Castro GR; Vicente G; da Rosa JS; Nader M; Pereira IA; Fröde TS
    Int Immunopharmacol; 2014 Aug; 21(2):481-6. PubMed ID: 24925756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging in Axial Spondyloarthritis: Evaluation of Inflammatory and Structural Changes.
    Maksymowych WP
    Rheum Dis Clin North Am; 2016 Nov; 42(4):645-662. PubMed ID: 27742019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etanercept for treating axial spondyloarthritis.
    Guillot X; Prati C; Sondag M; Wendling D
    Expert Opin Biol Ther; 2017 Sep; 17(9):1173-1181. PubMed ID: 28682112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of New Bone Formation in Axial Spondyloarthritis.
    Poddubnyy D; Sieper J
    Curr Rheumatol Rep; 2017 Sep; 19(9):55. PubMed ID: 28752489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axial spondyloarthritis.
    Sieper J; Poddubnyy D
    Lancet; 2017 Jul; 390(10089):73-84. PubMed ID: 28110981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of axial spondyloarthritis including ankylosing spondylitis.
    Braun J; Baraliakos X
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i97-103. PubMed ID: 21339229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors.
    Haynes KR; Pettit AR; Duan R; Tseng HW; Glant TT; Brown MA; Thomas GP
    Arthritis Res Ther; 2012 Nov; 14(6):R253. PubMed ID: 23171658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axial spondyloarthritis.
    Sieper J; Braun J; Dougados M; Baeten D
    Nat Rev Dis Primers; 2015 Jul; 1():15013. PubMed ID: 27188328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Golimumab for the treatment of axial spondyloarthritis.
    Gelfer G; Perry L; Deodhar A
    Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis.
    Christodoulou-Vafeiadou E; Geka C; Ntari L; Kranidioti K; Argyropoulou E; Meier F; Armaka M; Mourouzis I; Pantos C; Rouchota M; Loudos G; Denis MC; Karagianni N; Kollias G
    Arthritis Res Ther; 2020 Oct; 22(1):232. PubMed ID: 33023659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.